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Background: Several review studies have shown that 3.4% to 16.6% of patients in acute care hospitals experience
one or more adverse events. Adverse events (AEs) in hospitals constitute a significant problem with serious
consequences and a challenge for public health. The occurrence of AEs in Portuguese hospitals has not yet been
systematically studied. The main purpose of this study is to estimate the incidence, impact and preventability of
adverse events in Portuguese hospitals. It is also our aim to examine the feasibility of applying to Portuguese acute
hospitals the methodology of detecting AEs through record review, previously used in other countries.
Methods: This work is based on a retrospective cohort study and was carried out at three acute care hospitals in
the Administrative Region of Lisbon. The identification of AEs and their impact was done using a two-stage
structured retrospective medical records review based on the use of 18 screening criteria. A random sample of
1,669 medical records (representative of 47,783 hospital admissions) for the year 2009 was analyzed.
Results: The main results found in this study were an incidence rate of 11.1% AEs, of which around 53.2% were
considered preventable. The majority of AEs were associated with surgical procedures (27%), drug errors (18.3%)
and hospital acquired infections (12.2%). Most AEs (61%) resulted in minimal or no physical impairment or disability,
and 10.8% were associated with death. In 58.6% of the AEs’ cases, the length of stay was prolonged on average
10.7 days. Additional direct costs amounted to €470,380.00.
Conclusion: The magnitude of these results was critical, reinforcing the need of more detailed studies in this area.
The knowledge of the incidence and nature of AEs that occur in hospitals should be seen as a first step towards
the improvement of quality and safety in health care.
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Adverse events (AEs) occur with alarming frequency
in healthcare. These events represent significant losses
from a clinical, economic and social perspective [1-3].
To learn from these events and improve safety, they
must be identified, measured and their causes found.
Healthcare providers and researchers are searching for
an accurate, reliable and low cost method to identify
and measure AEs in hospital and other settings. The
method developed in the Harvard Medical Practice* Correspondence: paulo.sousa@ensp.unl.pt
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unless otherwise stated.Study, in the 90s, is the one most often used for national
AE studies [4].
Many countries, like Portugal, have taken initiatives
over the past decade to address safety problems in
health care [3,5,7,8]. The US report “To Err is Human”
marked an acceleration in programmes and actions for
increased patient safety initiated by health care policy
makers, health care professionals and managers [9]. As
far as we know there have been no studies to date on
the occurrence, nature, preventability and impact of AEs
in Portuguese hospitals.
Studies based on the “Harvard method” have been car-
ried out in several countries with different results, find-
ing evidence of 3.4% to 16.6% of patients in acute caretd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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Table 1 Screening criteria and number of medical records
showing evidence of one category of adverse event
Criteria n %
Hospital-incurred patient injury 101 22.4
Unplanned readmission after discharge from index
admission (12 months)
81 18.0
Unplanned admission related to previous healthcare
management
43 9.5
Hospital-acquired infection or sepsis 40 8.7
Adverse drug reaction 31 6.9
Unplanned return to the operating room 29 6.4
Any other undesirable outcomes not covered in this list
of criteria
28 6.2
Unexpected death 20 4.4
Unplanned transfer from general care to intensive care 17 3.8
Other patient complications 16 3.5
Cardiac or respiratory arrest 14 3.2
Unplanned removal, injury or repair of an organ during
surgery
10 2.2
Unplanned transfer to another acute care hospital 6 1.3
Development of neurological deficit not present on
admission
6 1.3
Inappropriate discharge to home 6 1.3
Dissatisfaction or correspondence indicating litigation 2 0.44
Injury related to abortion or delivery 1 0.22




The criteria are not mutually exclusive; i.e. one patient can have more than
one criterion (in 365 positive medical records there were 451 criteria).
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sults of these studies give data on a critical aspect of
hospital performance and stimulate patient safety im-
provement of each country.
The aims of this study were to estimate the incidence,
nature, preventability, cost and impact of adverse events
in Portuguese hospitals. This was an exploratory study
that also intended to examine the feasibility of applying
to Portuguese acute hospitals the methodology previ-
ously used in other countries.
Methods
This work followed a retrospective cohort study design.
The methods were based on the protocol used in the
Harvard Medical Practice Study [4,11,18] with modifica-
tions introduced in subsequent studies undertaken in the
United Kingdom, New Zealand, Canada, the Netherlands,
Sweden, Brazil, and, more recently, in a sample of 26
hospitals from eight developing and transitional coun-
tries [10-12,15-18].
The study was carried out in three public hospitals of
the Lisbon Administrative Region (these hospitals are
acute care hospitals; with 785 beds, 450 beds and 220
beds respectively; an emergency department, intensive
care units and a high surgery volume). Although the
participating hospitals were selected by convenience,
they reflect the major characteristics of other public
hospitals in Portugal regarding dimension (number of
beds), emergency department 24 hours per day, inten-
sive care units, medical and surgical departments and
casemix index of patients treated. No specialty hospitals
(e.g. Pediatric, Oncology, Obstetric) were included in
the study. A global random sample of 1,669 medical re-
cords was used, representative of 47,783 (3.5%) hospital
admissions, between 01 January 2009 and 31 December
2009, fulfilling the inclusion criteria for this study. At
each hospital a simple random sample was selected as-
suming the number of hospital admissions, an incidence
of AEs of 8% (based on The Canadian Adverse Events
Study) and a confidence level of 95% [12]. The sampling
frame included all admissions of patients over 18 years
old who had a minimum stay in hospital of 24 hours.
Hospital admissions with a primary diagnosis related to
psychiatry were excluded. Oversampling was carried out
with the expectation that 10% of medical records would
be unusable. A two-stage structured retrospective med-
ical records review was carried out based on the use of
18 screening criteria (Table 1).
In the first stage, a group of six nurses (two from each
hospital, with a minimum of five years experience in
clinical audits) assessed the medical records, looking for
the presence of, at least, one of the 18 criteria for the
presence of a potential adverse event. In stage two, a group
of five physicians (one Cardiologist, one Neurologist, twoSurgeons, one Internal Medicine, with a minimum of five
years experience in clinical codes and in clinical audits)
reviewed each positive record in order to confirm the
presence of an adverse event, to estimate its impact and
determine its preventability, according to the definition
established previously. The degree of agreement between
the reviewers in each stage was calculated (assessed on a
random sample of 10% of medical records) by using kappa
coefficient. Neither nurses nor doctors knew the previous
classification of their colleagues.
The timing of the AEs in relation to the hospital admis-
sion is an important methodological issue. We considered
AEs that occurred during the index hospital admission
and that were detected during either the index or subse-
quent hospital admissions over the following 12-month
period (in the same hospitals).
Similarly to other studies, physicians estimated, based
on evidence in the medical record and their professional
judgment, the impact of AEs in two different ways: i) the
degree of physical impairment or disability at discharge
(minimal, moderate or permanent), or death; ii) the num-
ber of additional hospital days directly attributable to AEs.
Table 2 Degree of physical impairment or disability at
discharge
n %
Minimal impairment or disability, recovery within 1 month 113 61.0%
Moderate impairment or disability, recovery within 1-12
months
8 4.1%
Permanent impairment or disability 11 5.7%
Death 20 10.8%
Unable to determine 34 18.4%
Total (of AEs) 186 100%
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estimated based on official accounting data from all the
NHS hospitals, providing information on daily costs.
This value includes hospital daily costs, namely physi-
cians' and nursing staff, lab tests and exams, medication,
housing and overhead [19].
Using professional judgment and based on the infor-
mation of medical records, the physician reviewers also
classified the preventability of each AE using a six-point
scale (1- virtually no evidence of preventability; 2- slight
to modest evidence of preventability; 3- Preventability
not quiet likely less than 50/50, but “close to call”; 4-
preventability more than likely 50/50; 5- strong evidence
of preventability; and 6 -virtually certain evidence of pre-
ventability. The preventability of an adverse event was
considered with a score > = 4).
SPSS (version 19) was used for data processing and for
statistical analysis. The study was approved by the Ethics
Committee of participating hospitals.Results
One or more of the criteria for an adverse event were
identified in 365 out of the 1.669 medical records reviewed
(22%). Of these 365 records, those which passed to the
second screening, 186 (51%), were confirmed as an AE, an
overall incidence rate of 11.1% (186/1669) with a 95% CI
(9.6%; 12.6%). The highest proportions of AEs identified
were related to surgical procedures (27.0%), drug errors
(18.3%) and hospital-acquired infection (12.2%). Most
of the AEs (59.2%) occurred in patients aged 65 or over
(Figure 1).
Most (61%) of the AEs resulted in no physical or min-
imal impairment or disability, and were satisfactorily re-
solved during the admission, or within one month from
discharge. Nevertheless, the criteria applied estimated
that 5.4% of the AEs resulted in permanent disability
according to the definition and 10.8% associated with
death (Table 2).Figure 1 Percentage distribution of adverse events by
age group.We found that most of the patients, 109/186 (58.6%),
who experienced AEs incurred extra bed days in hospital
(a total of 1,166 extra days, an average of 10.7 days per
patient, ranging from 1-70 days), with additional total
costs of €470,380.00 for all three hospitals together.
Concerning preventability, 53.2% were classified as
preventable (Table 3).
The reliability of the assessment of the screening cri-
teria performed by nurses (first screening) was consid-
ered good – substantial agreement (k = 0.63; IC 0.43;
0.79 and p < 0.001; 83.5% agreement). Among doctors
(second screening), the reliability of determination of
AEs was also good (k = 0.78; IC 0.49; 1 and p < 0.001;
86% agreement) and that of preventability was consid-
ered fair (k = 0.58; IC 0.23; 0.94 and p = 0.009; 79%
agreement) (Table 4).Discussion
We used retrospective medical record review following
the HMPS methodology in order to assess the nature, inci-
dence, and clinical and/or economic impact of adverse
events and to provide some information on their causes.
Studies in many countries have followed the same meth-
odology and have come to broadly similar conclusions
[10-12,14-17]. Rates of AEs in most recent studies lie be-
tween 8% and 12%, a range now accepted as being com-
mon in the healthcare systems of developed countries.Table 3 Level of preventability of the AEs
n % Preventability
Virtually no evidence of preventability 43 23.1%
46.8% not
preventable
Slight to modest evidence of
preventability 23 12.4%
Preventability not quite likely (less than
50/50, but “close call”) 21 11.3%
Preventability more than likely (more than
50/50 but “close call” 26 14.0%
53.2%
PreventableStrong evidence of preventability 51 27.4%
Virtually certain evidence of preventability 22 11.8%
Total 186 100% 100%
Table 4 Reliability of assessment between reviewers in the first and the second screening
Question Screening K statistic CI 95% p-value
Presence of one or more positive criteria in the medical record analyzed Screening 1 0.63 (83.5% agreement) (0.43; 0.79) < 0.001
AE confirmed by physician Screening 2 0.78 (89% agreement) (0.49; 1) < 0.001
Level of preventability (scale 1–6) Screening 2 0.58 (79% agreement) (0.23; 0.94) 0.009
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which 53.2% were considered as preventable. The assess-
ment of preventability is one challenge for these studies,
and indicates the potential gains to be achieved by im-
provements. For this reason, analysis of each case is
needed to decide prevention strategies. On the other hand,
the classification of preventable AEs, while using a clear
criterion and standard, still involves a subjective element
and may vary with the expertise, practical experience of
the physician and the way the data is registered in the
medical record. Some authors argue that knowing the out-
come and its severity may influence the judgment of caus-
ation and preventability and that the bias element is likely
to be in the direction of overestimation of the rate of
“preventable” AEs (hindsight bias) [20-22]. Neverthe-
less, our results are similar to the findings of previous
studies, particularly those of the UK (incidence10.8%
and 52% preventable), New Zealand (incidence 11.3%
and 61.6% preventable) and the Danish study (incidence
9.0% and 40.4% preventable) [10,11,23].
One finding was that 59.2% of patients who experi-
enced an AE were 65 years old or older. Relatively little
attention has been paid to patient safety in older people
although they are particularly vulnerable to healthcare
error and harm [24,25]. Moreover, older people are
more likely to suffer from multiple health conditions,
receive multiple treatments, and stay longer in hospital.
A longer stay increases the risk of all complications of
hospitalization. In the last decades more people are liv-
ing longer and this trend is likely to continue. For all
these reasons, it is our opinion that safety for older pa-
tients should receive higher priority in research and in
safety prevention strategies.
The majority of AEs (61%) were not documented as
causing serious consequences for the patient. They did
not result in any significant physical impairment or dis-
ability, and were resolved during the admission or,
within one month from discharge. This is a similar per-
centage to that reported in other studies [3,10,12,13,17].
However, a meaningful proportion of patients died
(10.8%) or experienced a permanent disability as a result
of their AEs (5.4%).
The economical impact of adverse events has been
gaining particular attention in the last years [26,27]. The
report of the Institute of Medicine estimates that, in the
United States, the total national costs associated with ad-
verse events represent approximately 4% to 6% of nationalhealth expenditures [9]. In Britain, the cost of preventable
AEs, in lost bed days alone, was estimated in one billion
(Pounds) per year [24]. In the Netherlands (the Dutch ad-
verse events study) the authors concluded that 3% of all
bed days and 1% of the total health budget could be attrib-
uted to preventable AEs (costs of direct hospital care,
mainly additional time in hospital) [20]. In our study, most
of the patients (58.6%) who experienced AEs prolonged
the length of stay in hospital on average 10.7 days, with
additional direct costs of €470,380.00. Extrapolating this
estimated value to the population of the study (all admis-
sion of the three hospitals in 2009) the costs varied be-
tween €1,290.310 and €1,691.643. The overall real costs
are higher, as these estimates do not include additional
treatments in ambulatory care or other hospitalizations
(which are related to the same AE), costs to patients (e.g.
medication in ambulatory) or any societal costs (e.g. ab-
sence from work, premature death). The costs of preven-
tion, however, may be significant, especially if organizations
or their health systems do not have effective implementa-
tion capacity [27].
In addition to the costs of unnecessary suffering caused
to patients and families, the costs and savings of adverse
events are a critical issue in Portugal, which will be experi-
encing a challenging economic situation for at least the
next five years [28] . As with some other European coun-
tries, the economic rationale is increasing for selecting ef-
fective strategies and implementing them in a context
which rewards safety improvement [27]. Including an eco-
nomic dimension to the knowledge gained from research
into quality and safety is an important part of the health
system reform that is being implemented in Portugal
[5,12,29,30]. Moreover, it could be a starting point for spe-
cific interventions in the improvement of patient safety
and it may help to prioritise research areas for the near fu-
ture [6,20,27,31].
There are limitations to the study. These include those
applying to retrospective studies, such as information bias
and hindsight bias [15,21,22]. We observed that the quality
of patient records could be better, although this did not
significantly limit the study. Retrospective patient record
studies still represent the “gold-standard” method for
assessing incidence and monitoring the frequency of AEs
[13,20,31,32] and the use of similar methods to those used
elsewhere allows comparisons to be made. However, for a
more comprehensive assessment of safety, other methods
also need to be used, including reporting and learning
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and morbidity and mortality reviews [13,33].
The reliability of the review process is another critical
element in these studies [34,35]. In our study, the level
of agreement (Kappa statistic – k value) between nurses
was considered good - substantial agreement (k value
0.63) and is related to the identification of the presence
of at least one positive criterion in the first screening.
This value is in line with those found in other studies
[11-13,15]. Among doctors (in the second screening),
the reliability of determination of AEs was also consid-
ered good - substantial agreement with k value of 0.78
and fair concerning their preventability, with k value of
0.58. For the second screening, the k value is slightly
higher than those found in other studies undertaken at
national level (e.g. Canada, New Zealand, Sweden and
The Netherlands). These results must be carefully inter-
preted, due to the small number of reviewers, cases and
hospitals involved in this study [36,37].
Conclusions
In Portugal, there is an overall awareness and a growing
concern about patient safety issues. This study suggests
that AEs in three Portuguese hospitals affect nearly one
in ten patients and results in considerable avoidable suf-
fering and economic costs. With local evidence of the
size of the problem, staff is more motivated to act, espe-
cially if effective interventions to reduce adverse events
can be selected and implemented to target those AEs
that are prioritized, namely those resulting from surgical
procedures, drug errors and health-acquired infections.
If interventions can be implemented and demonstrated
to be cost-effective, then more healthcare managers and
policy makers may begin to view improvements in safety
as an investment rather than an expense. This can also
speed changes in incentives so as to reward safety and
quality. Local evidence of the size and nature of the
problem and its clinical and cost impact is one of the
first steps toward this desirable change.
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